The Catalog / Resources / Adding GLP-1 Weight Management
Provider education · program launch
GLP-1 is the fastest-growing line in aesthetics and wellness, and the most common way to lose money on it is to build it backwards. This guide lays out the sequence that works — prescriber, pharmacy, platform, patients — the compounded-medication reality you have to state honestly, and the six-week program model. For practice owners.
The right sequence isn't a preference, it's the difference between a program that compounds and one that burns cash. The order is: foundation, then conversion path, then fuel. Foundation means prescriber coverage, pharmacy fulfillment, and intake/payment flows working end-to-end. Conversion path means booking, checkout, and the patient portal tested — so every click has somewhere to land. Only then do you switch on growth, with tracking and full ad-spend transparency.
Medical director / prescriber coverage for the states you serve.
503A and/or 503B fulfillment wired to your consults.
Intake, checkout, and portal tested end-to-end.
Growth switched on only when the machine underneath is ready.
In most states you can't prescribe GLP-1 therapy without a medical director or appropriate prescriber coverage for the jurisdictions your patients are in. This is the first domino — no coverage, no program. A doctor's network can provide directorship and on-demand licensed consults across all 50 states through one relationship, and the key term to protect is ownership: structure it so your patients, records, and data belong to your practice. Our guide to getting a medical director in all 50 states covers the ownership trap in detail, and the doctor's network page shows how coverage works.
That language is the compliance floor, and it shapes what your practice can honestly say in its marketing and to patients. Never describe a compounded GLP-1 product as FDA-approved or as equivalent to an approved brand-name drug. Where a program uses compounded therapy, that fact belongs on the page, on the consent, and in the conversation.
On fulfillment: most practices use both pharmacy types — 503A for patient-specific prescriptions shipped direct to telehealth patients, and 503B for standardized office stock. If that distinction is new, read the 503A vs 503B guide, then set up access through a pharmacy network so you're comparing verified options instead of depending on a single relationship.
Before a single patient enters the funnel, these three have to work together:
A branded EHR ties intake to consult to fulfillment; the supplies marketplace covers the syringes and administration materials patients and staff need. Get these connected before you spend a dollar on ads.
Not every weight patient is a candidate for — or wants — injectable therapy, and building a second lane keeps price-sensitive patients inside your practice. A six-week, provider-supervised app-guided program pairs an all-natural regimen with a structured nutrition plan and a patient app — tracking, education, and provider chat included — followed by a maintenance phase that keeps patients engaged with your practice. The app handles tracking and education, which reduces staff time per patient, and the built-in maintenance phase creates recurring revenue after week six.
It fits patients transitioning off injectable weight-loss therapy, patients who aren't candidates for it, and price-sensitive patients you'd otherwise lose. Run it as a complement to a GLP-1 line, not a replacement — the two serve different patients. See how the packaged program is structured on the programs page.
A GLP-1 line and a companion program add revenue lines with different cost structures: the injectable line carries prescriber and pharmacy economics, the app-guided program runs with no capital equipment and a maintenance phase that recurs. Beyond that, the honest answer is that results and returns vary by practice and by patient, and no income or outcome is guaranteed. Model your own numbers — patient volume, program pricing, fulfillment costs — the same disciplined way you'd model a device purchase. What this guide can promise is the sequence; the economics are yours to build.
Common questions
Prescriber coverage first, then pharmacy fulfillment, then the platform and intake flow, then patients and marketing. Most clinics fail by buying ads before their foundation can convert them — sending clicks into a funnel with no prescriber coverage and no fulfillment. Build the machine before you fuel it.
No. Compounded medications are not FDA-approved, and the FDA does not review compounded medications for safety or efficacy. They are prepared by state-licensed 503A pharmacies and FDA-registered 503B outsourcing facilities pursuant to prescriptions or medication orders from licensed providers.
A medical director or prescriber coverage for the states you serve, access to 503A and/or 503B compounding pharmacies, and an intake/EHR flow so patients move from consult to fulfillment without bottlenecks. Marketing comes only after those three work end-to-end.
Yes. A six-week, provider-supervised app-guided weight program pairs an all-natural regimen with a structured nutrition plan and a patient app, followed by a maintenance phase. It fits patients who aren't candidates for — or are transitioning off — injectable therapy, or who are price-sensitive.
The shortcut
Eventide sets up prescriber coverage, pharmacy fulfillment, and the program model in the right order — and will tell you honestly if your foundation isn't ready before any spend. A 30-minute call maps it, no cost, no obligation.
Book a strategy call
30 minutes · Zoom · no cost, no obligation
Pick a time →Prefer to talk now? 810-588-9612 · justin@eventideaw.com
Or see Programs & Growth →
Written by Justin Messner · Last reviewed: July 9, 2026
Educational content — not legal, medical, or financial advice. This is educational information for licensed medical providers and practice owners; requirements vary by state and license type. All programs are offered under the supervision of licensed medical providers; program availability varies by state and license type. Compounded medications are not FDA-approved; the FDA does not review compounded medications for safety or efficacy. Program products are not represented as FDA-approved to diagnose, treat, cure, or prevent any disease. Results from any weight program vary by individual and no outcomes are guaranteed; no income or revenue is claimed or guaranteed. Eventide is not a pharmacy or medical practice and does not prescribe, dispense, or supervise clinical services. Consult your healthcare attorney and financial advisor before launching a program.